Ennovance Capital

Description

• Ennovance Capital LLC (ECL) is in one business only alternative asset investments and enhancing our portfolios value. We are not in the investment banking, brokerage, or advisory businesses. I. Private Equity: Ennovance is a niche industry-focused investor in middle-market companies, with exclusive focus on chemical, specialty materials, pharmaceuticals, health-care, water, energy, petrochemical and chemistry related sectors. For our representative segments of investment interest, please visit: http://ennovance.com/index_files/Interest.htm End markets for related products and services in these industries vary widely, such as: water and waste treatment, functional additives, renewable energy, fine chemicals, medical devices or electronics, biodegradable plastics, coatings, food & beverage, flavor, fragrance, beauty & personal care, hygiene & cleaning solutions for hospitals or general applications, preservatives, fertilizers, catalysts, contract manufacturing & research, laboratory supplies, safety or security solutions, and so on. We focus on structuring acquisitions that meet the unique requirements of each strategic seller, navigating all aspects of deal complexities. From public-to-private transactions to corporate divestitures of non-core assets, we are skilled at mitigating all degrees of risk when extracting a non-core division from its parent, maintaining business momentum, and ensuring business continuity. II. Other Alternate Assets:Please contact us at: info@ennovance.com For more information, please visit: www.ennovance.com
• 

  Headquarters:1518 Walnut Street Suite 16106, Philadelphia, Pennsylvania, United States

  More
• 

  Phone Number: +1 800-901-1006

• 

  Website: https://www.ennovance.com

• 

  Employees:7

• 

  Revenue:$1 - 10M

• 

  Legal Name:Ennovance Capital

• Ennovance Capital's Social Media

  
• Is this data correct?

• |  NAICS Code: 561990  |

  Show More